Successful Treatment and Secondary Prevention of Venous Thrombosis Secondary to Behçet Disease with Rivaroxaban

We here present the successful initial treatment and secondary prophylaxis of superficial venous thrombosis secondary to Behçet's disease by a novel anticoagulant drug, rivaroxaban (Xarelto®). To our knowledge, this is the first case of using an oral direct inhibitor of FXa in this setting. Our...

Descripción completa

Detalles Bibliográficos
Autores principales: Boban, Ana, Lambert, Catherine, Hermans, Cedric
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2016
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942626/
https://www.ncbi.nlm.nih.gov/pubmed/27437154
http://dx.doi.org/10.1155/2016/2164329

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4942626/
https://www.ncbi.nlm.nih.gov/pubmed/27437154
http://dx.doi.org/10.1155/2016/2164329

Ejemplares similares